Successful Treatment of Animal Models of Rheumatoid Arthritis With Small-Molecule Cyclin-Dependent Kinase Inhibitors

Journal of Immunology - United States
doi 10.4049/jimmunol.180.3.1954
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Small Molecule FLT3 Tyrosine Kinase Inhibitors

2012English

Animal Models of Rheumatoid Arthritis: How Informative Are They?

European Journal of Pharmacology
Pharmacology
2015English

A Cyclin-Dependent Kinase Inhibitor, Dinaciclib in Preclinical Treatment Models of Thyroid Cancer

PLoS ONE
Multidisciplinary
2017English

FRI0082 Ras Signaling Inhibitors Attenuate Arthritis in Animal Models of Rheumatoid Arthritis by Down Modulating the Pathogenic Th17 Cell Response

2017English

Small Molecule Tyrosine Kinase Inhibitors in Pancreatic Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Treatment of Rheumatoid Arthritis With ATP

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1949English

Identification of Small Molecule Inhibitors That Block theToxoplasma gondiiRhoptry Kinase ROP18

ACS Infectious Diseases
Infectious Diseases
2016English

Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis

Journal of Managed Care Pharmacy
2014English

Treatment of Rheumatoid Arthritis

Rheumatology
RheumatologyPharmacology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy